CUV
Click for more information
1.61% $14.68 clinuvel pharmaceuticals limited

nomura "maa review should complete by start 4q, page-8

  1. frank2you1965
    44 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    11/02/12
    03:06
    Post #: 9678626
    Don't forget the turnover/sales for EPPuse after EMA approval. In Europa there are apr. 3.500 EPP patients.

    3.500 x apr. € 30.000 = 105 mln.

    If only half of the patients are going to use Scenesse Clinuvel will be a profitable biotechcompany.
    CUV Price at posting: $1.93 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

KAI Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
right-arrow Created with Sketch.
MAG Magmatic defines 6km copper trend with grades of up to 6.5% at NSW prospect
right-arrow Created with Sketch.
STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
AVH Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
right-arrow Created with Sketch.
TG1 TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.68 		Change
-0.240(1.61%) 		Mkt cap ! $735.1M
Open High Low Value Volume
$14.75 $14.92 $14.65 $503.5K 34.18K

Buyers (Bids)

No. Vol. Price($)
1 448 $14.68
 

Sellers (Offers)

Price($) Vol. No.
$14.74 149 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.